EXHIBIT 10.6(b)AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENT          THIS AMENDMENT NO. 1 TO EXECUTIVE EMPLOYMENT AGREEMENT (this “Amendment”) by and between MylanLaboratories Inc., a Pennsylvania corporation (the “Company”) and Edward J. Borkowski (the“Executive”), is made as of April 3, 2006.          WHEREAS, the Company and the Executive are parties to that certain Executive EmploymentAgreement dated as of July 1, 2004 (the “Agreement”);          WHEREAS, the Company and the Executive wish to amend and extend the Agreement, effective as ofApril 1, 2006, as set forth below;          NOW, THEREFORE, for good and valuable consideration, the receipt and adequacy of which arehereby acknowledged, the parties hereto, intending to be legally bound, agree as follows: 1. Section 2 of the Agreement is hereby deleted and replaced in its entirety to read asfollows:“Effective Date; Termination of Employment. This Agreement shall commence and be effective asof the date hereof and shall remain in effect, unless earlier terminated or extended orrenewed, as provided in Section 8 of this Agreement, through June 30, 2008.” 2. Section 9(c) of the Agreement is hereby deleted and replaced in its entirety by thefollowing:“Termination without Cause. If Mylan discharges Executive without Cause, Mylan will payExecutive, within 30 days of his separation from the Company, a lump sum equal to one andone-half (1.5) times the sum of his then current Base Salary plus Prior Bonus. Mylan shallalso pay the cost of continuing Executive’s health insurance benefits for the 18 monthsfollowing such termination without Cause; provided, however, that in the case of healthinsurance continuation, Mylan’s obligation to provide health insurance benefits shall end atthe time as Executive obtains health insurance benefits through another employer or otherwisein connection with rendering services for a third party. Executive will continue to be boundby all provisions of this Agreement that survive termination of employment.” 3. The following proviso is hereby added to the end of the final sentence of Section9(d) of the Agreement:“provided, however, that such consideration, compensation, and benefits shall be reduced by anybenefits that the Executive or the Executive’s estate or beneficiaries are entitled to pursuantto plans or arrangements of the Company.”
 

 
 4. The following is hereby added as Section 9(h) of the Agreement:“Section 409A. Notwithstanding anything to the contrary in this Agreement, the payment ofconsideration, compensation, and benefits pursuant to this Section 8 shall be interpreted andadministered in a manner intended to avoid the imposition of additional taxes under Section409A of the Internal Revenue Code.” 5. This Amendment shall be governed by, interpreted under and construed in accordancewith the laws of the Commonwealth of Pennsylvania.  6. This Amendment may be executed in counterparts, each of which shall be an originaland all of which shall constitute the same document.  7. Except as modified by this Amendment, the Agreement is hereby confirmed in allrespects.          IN WITNESS WHEREOF, this Amendment has been duly executed and delivered as of the date and theyear first written above.         MYLAN LABORATORIES INC.         By:  /s/ Robert J. Coury          Name: Robert J. Coury  Title: Vice Chairman and CEO         EXECUTIVE           /s/ Edward J. Borkowski       Edward J. Borkowski
2